Dendritic cell-based (DC-based) vaccines are promising immunotherapies for cancer. However, several factors, such as the lack of efficient targeted delivery and the sources and types of DCs, have limited the efficacy of DCs and their clinical potential. We propose an alternative nanotechnology-based vaccine platform with antibacterial prophylactic abilities that uses gold glyconanoparticles coupled to listeriolysin O 91-99 peptide (GNP-LLO), which acts as a novel adjuvant for cancer therapy. GNP-LLO, when used to vaccinate mice, exhibited dual antitumour activities, namely, the inhibition of tumour migration and growth and adjuvant activity for recruiting and activating DCs, including those from melanoma patients. GNP-LLO nanoparticles caused tumour apoptosis and induced antigen- and melanoma-specific cytotoxic Th1 responses (P ≤ 0.5). We propose this adjuvant nanotherapy for preventing the progression of the first stages of melanoma.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1039/c7nr02494k | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Systematic Investigation of Cellular Response to Hydroxyl Group Orientation Differences on Gold Glyconanoparticles.
ACS Omega
November 2023
Department of Chemistry & Biochemistry, Augusta University, Augusta, Georgia 30912, United States.
Nanoparticle (NP) surfaces act as the interface as they interact with living systems and play a critical role in defining their cellular response. The nature of these interactions should be well understood to design safer and more effective NPs to be used in a wide range of biomedical applications. At the moment, it is not clear how a subtle change in surface chemistry will affect an NP's behavior in a biological system.
View Article and Find Full Text PDFPhotodynamic therapy (PDT) uses a non-toxic light sensitive molecule, a photosensitiser, that releases cytotoxic reactive oxygen species upon activation with light of a specific wavelength. Here, glycan-modified 16 nm gold nanoparticles (glycoAuNPs) were explored for their use in targeted PDT, where the photosensitiser was localised to the target cell through selective glycan-lectin interactions. Polyacrylamide (PAA)-glycans were chosen to assess glycan binding to the cell lines.
View Article and Find Full Text PDFPolymer-tethered glyconanoparticle colourimetric biosensors for lectin binding: structural and experimental parameters to ensure a robust output.
RSC Adv
November 2022
Department of Chemistry, University of Warwick CV4 7AL UK
Article Synopsis
- - Glycan-lectin interactions are critical in biological processes like pathogen attachment and immune response, but current methods to study these interactions are often expensive and not widely accessible.
- - Recently developed glycosylated plasmonic nanoparticles offer a cost-effective biosensor alternative that detects glycan-protein binding through noticeable color changes, which can be analyzed with simple equipment.
- - This research suggests optimal parameters (gold core size and polymer tether length) for using these nanoparticles, allowing lab users to efficiently investigate new glycan/protein interactions with minimal optimization needed.
Gold Glyconanoparticles Combined with 91-99 Peptide of the Bacterial Toxin, Listeriolysin O, Are Efficient Immunotherapies in Experimental Bladder Tumors.
Cancers (Basel)
May 2022
Grupo de Oncología y Nanovacunas, Instituto de Investigación Marqués de Valdecilla (IDIVAL), 39011 Santander, Cantabria, Spain.
This study presents proof of concept assays to validate gold nanoparticles loaded with the bacterial peptide 91-99 of the listeriolysin O toxin (GNP-LLO nanovaccines) as immunotherapy for bladder tumors. GNP-LLO nanovaccines showed adjuvant abilities as they induce maturation and activation of monocyte-derived dendritic cells (MoDCs) to functional antigen-presenting cells in healthy donors and patients with melanoma or bladder cancer (BC), promoting a Th1 cytokine pattern. GNP-LLO nanovaccines were also efficient dendritic cell inducers of immunogenic tumor death using different bladder and melanoma tumor cell lines.
View Article and Find Full Text PDFSynthetic Glyconanoparticles Modulate Innate Immunity but Not the Complement System.
ACS Appl Bio Mater
May 2022
Department of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces, Am Mühlenberg 1, 14476 Potsdam, Germany.
Nanoparticles that modulate innate immunity can act as vaccine adjuvants and antigen carriers and are promising alternatives to conventional anticancer therapy. Nanoparticles might, upon contact with serum, activate the complement system that might in turn result in clearance and allergic reactions. Herein, we report that ultrasmall glyconanoparticles decorated with nonimmunogenic α-(1-6)-oligomannans trigger an innate immune response without drastically affecting the complement system.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!